
### [Orphanet:97992](http://www.orpha.net/ORDO/Orphanet_97992)
**Label:** Rare hematologic disease

**Subclasses:** [Orphanet:167714](http://www.orpha.net/ORDO/Orphanet_167714) (Unclassified acute myeloid leukemia), [Orphanet:519](http://www.orpha.net/ORDO/Orphanet_519) (Acute myeloid leukemia), [Orphanet:86851](http://www.orpha.net/ORDO/Orphanet_86851) (Acute leukemia of ambiguous lineage), [Orphanet:98277](http://www.orpha.net/ORDO/Orphanet_98277) (Acute myeloid leukemia with recurrent genetic anomaly), [Orphanet:440731](http://www.orpha.net/ORDO/Orphanet_440731) (L-ferritin deficiency), [Orphanet:513](http://www.orpha.net/ORDO/Orphanet_513) (Acute lymphoblastic leukemia), [Orphanet:547](http://www.orpha.net/ORDO/Orphanet_547) (Non-Hodgkin lymphoma), [Orphanet:86816](http://www.orpha.net/ORDO/Orphanet_86816) (Congenital analbuminemia), [Orphanet:52688](http://www.orpha.net/ORDO/Orphanet_52688) (Myelodysplastic syndrome), [Orphanet:86846](http://www.orpha.net/ORDO/Orphanet_86846) (Therapy related acute myeloid leukemia and myelodysplastic syndrome), [Orphanet:98292](http://www.orpha.net/ORDO/Orphanet_98292) (Mastocytosis), [Orphanet:389](http://www.orpha.net/ORDO/Orphanet_389) (Langerhans cell histiocytosis), 

**Corr. equiv. classes:** [OMIM:604856](http://purl.obolibrary.org/obo/OMIM_604856), [Orphanet:98277](http://www.orpha.net/ORDO/Orphanet_98277), [Orphanet:52688](http://www.orpha.net/ORDO/Orphanet_52688), [Orphanet:98292](http://www.orpha.net/ORDO/Orphanet_98292), [Orphanet:86846](http://www.orpha.net/ORDO/Orphanet_86846), [OMIM:605027](http://purl.obolibrary.org/obo/OMIM_605027), [Orphanet:86816](http://www.orpha.net/ORDO/Orphanet_86816), [OMIM:601626](http://purl.obolibrary.org/obo/OMIM_601626), [OMIM:614286](http://purl.obolibrary.org/obo/OMIM_614286), [OMIM:613065](http://purl.obolibrary.org/obo/OMIM_613065), [OMIM:616000](http://purl.obolibrary.org/obo/OMIM_616000), [OMIM:247640](http://purl.obolibrary.org/obo/OMIM_247640), [Orphanet:86851](http://www.orpha.net/ORDO/Orphanet_86851), [OMIM:613067](http://purl.obolibrary.org/obo/OMIM_613067), [OMIM:154800](http://purl.obolibrary.org/obo/OMIM_154800), [Orphanet:440731](http://www.orpha.net/ORDO/Orphanet_440731), [Orphanet:519](http://www.orpha.net/ORDO/Orphanet_519), [Orphanet:167714](http://www.orpha.net/ORDO/Orphanet_167714), [Orphanet:547](http://www.orpha.net/ORDO/Orphanet_547), [OMIM:615604](http://purl.obolibrary.org/obo/OMIM_615604), [Orphanet:389](http://www.orpha.net/ORDO/Orphanet_389), [Orphanet:513](http://www.orpha.net/ORDO/Orphanet_513), 

**Class expressions from DL-Learner:**

- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 24.67%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 24.59%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 24.50%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 24.50%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 24.50%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 24.50%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 24.50%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 24.43%
- Thing 22.19%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 22.19%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 21.12%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 20.86%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 19.90%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 19.83%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 15.46%


